000			04932nam a22003615i 4500
001			235335
003			ES-VaUE
005			20221220020659.0
007			cr nn 008mamaa
008			161007s2017 xxu| s |||| 0|eng d
020			_a9781493964451
024	7		_a10.1007/978-1-4939-6445-1 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC
245	1	0	_aVaccine Adjuvants _bMethods and Protocols _cedited by Christopher B. Fox.
250			_a1st edition 2017
264		1	_aNew York, NY _bSpringer International Publishing _c2017
300			_a1 recurso en línea (XII, 372 páginas) _b75 ilustraciones, 33 ilustraciones a color
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_aarchivo de texto _bPDF
490	0		_aMethods in Molecular Biology _x1940-6029 _v1494
505	0		_aOverview of Vaccine Adjuvants: Introduction, History, and Current Status -- Development of the CpG Adjuvant 1018: A Case Study -- Syntheses of Human TLR8-Specific Small-Molecule Agonists -- Semisynthesis of Analogues of the Saponin Immunoadjuvant QS-21 -- QS-21 Adjuvant: Laboratory-Scale Purification Method and Formulation into Liposomes -- Purification of an Immunoadjuvant Saponin Fraction from Quillaja brasiliensis Leaves by Reverse-Phase Silica Gel Chromatography -- Biosynthetic Approaches to Squalene Production: The Case of Yeast -- In Silico Adjuvant Design and Validation -- Manufacturing Methods for Liposome Adjuvants -- Synthesis of Lymph Node-Targeting Adjuvants -- Preparing an Adjuvanted Thermoresponsive Gel Formulation for Sublingual Vaccination -- Manufacture of Oil-in-Water Emulsion Adjuvants -- Methods to Prepare Aluminum Salt-Adjuvanted Vaccines -- Production of Adjuvant-Loaded Biodegradable Particles for Use in Cancer Vaccines -- Lyophilization of Adjuvanted Vaccines: Methods for Formulation of a Thermostable Freeze Dried Product -- Stressed Stability Techniques for Adjuvant Formulations -- Particle Sizing of Nanoparticle Adjuvant Formulations by Dynamic Light Scattering (DLS) and Nanoparticle Tracking Analysis (NTA) -- Quantification of Multiple Components of Complex Aluminum-Based Adjuvant Mixtures by Using Fourier Transform Infrared Spectroscopy and Partial Least Squares Modeling -- Determination of Protein Content in Alhydrogelâ-Based Vaccines by O-Phthalaldehyde Assay -- Staining and Transfer Techniques for SDS-PAGE Gels to Minimize Oil-in-Water Emulsion Adjuvant Interference -- Interactions Between Antigens and Nanoemulsion Adjuvants: Separation and Characterization Techniques -- Screening Vaccine Formulations in Fresh Human Whole Blood -- Analysis of the Innate Response to Adjuvants: Characterization of the Draining Lymph Node by Fluorescence-Activated Cell Sorting -- Assessment of Antigen-Specific Cellular Immunogenicity Using Intracellular Cytokine Staining, ELISpot, and Culture Supernatants -- Eliciting Epitope-Specific CD8 T Cell Response by Immunization with Microbial Protein Antigens Formulated with α-Galactosylceramide: Theory, Practice, and Protocols -- Molecular Methods and Bioinformatic Tools for Adjuvant Characterization by High-Throughput Sequencing.
520			_aThis collection seeks to elucidate the practical methods necessary for successful adjuvant development, with a particular focus on the synthesis, formulation, manufacturing, and characterization aspects involved. Beginning with an overview and a case study, the book then delves into in silico design, chemical synthesis, biosynthesis, and/or purification from natural raw materials of specific adjuvant molecules, adjuvant formulation approaches, the analytical characterization of adjuvant formulations and adjuvant-containing vaccines, as well as the biological characterization of vaccine adjuvant activity, including in vitro and in vivo approaches, to measure innate and adaptive immune responses. Written in the highly successful Methods in Molecular Biology format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Practical and authoritative, Vaccine Adjuvants: Methods and Protocols aims to facilitate vaccine adjuvant product development efforts, making them more accessible, manufacturable, and better characterized.
700	1		_aFox, Christopher B _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9781493964437
776	0	8	_iPrinted edition: _z9781493964444
776	0	8	_iPrinted edition: _z9781493982028
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-4939-6445-1 _z(usuarios Universidad Europea de Valencia)
942			_2lcc _cLE
988			_aSpringer_Protocols_2017
999			_c235335 _d235335